not-yet-known not-yet-known not-yet-known unknown Site visit with James Watson and David Baltimore I had moved from the Chemotherapy Program (whose funding had changed) to the Chemical Carcinogenesis Program with Chris Michejda, and soon faced a site visit with two famous Nobel Prize winners. These molecular biologists were much more in tune with molecular biology work like mine, rather than the work of the chemists. They loved the forefront genetic construction I had used that could detect carcinogenic substances in 4 hours. I was pregnant at the time and not really focused on science, so I wasn’t nervous like everyone else. When Watson complimented my presentation in public, that gave me license to chart my own path forward, working part time after Catherine was born. Soon after, I published the Gilvocarcin paper in Science. As I was a shy and naïve young person, and a female to boot, the established molecular biologists could hardly believe it. Their skepticism and incredulity were obvious. But then they accepted me (not just because my husband was the director) and left me alone, even providing me with a post-doc who turned out to be all thumbs in the lab.